Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[Occult hepatitis B reactivation in a patient with homozygous sickle cell disease: clinical case and literature review].

Diop M, Cisse-Diallo VMP, Ka D, Lakhe NA, Diallo-Mbaye K, Massaly A, Dièye A, Fall NM, Badiane AS, Thioub D, Fortes-Déguénonvo L, Lo G, Diop CT, Ndour CT, Soumaré M, Seydi M.

Pan Afr Med J. 2017 Oct 10;28:127. doi: 10.11604/pamj.2017.28.127.13640. eCollection 2017. Review. French.

2.

Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.

Chen GD, Gu JL, Qiu J, Chen LZ.

Transpl Infect Dis. 2013 Jun;15(3):300-5. doi: 10.1111/tid.12065. Epub 2013 Mar 8.

PMID:
23473005
3.

Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Elkady A, Aboulfotuh S, Ali EM, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Iijima S, Tanaka Y.

World J Gastroenterol. 2013 Oct 7;19(37):6214-20. doi: 10.3748/wjg.v19.i37.6214.

4.

Diagnostic strategy for occult hepatitis B virus infection.

Ocana S, Casas ML, Buhigas I, Lledo JL.

World J Gastroenterol. 2011 Mar 28;17(12):1553-7. doi: 10.3748/wjg.v17.i12.1553. Review.

5.

Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection.

Kamitsukasa H, Iri M, Tanaka A, Nagashima S, Takahashi M, Nishizawa T, Okamoto H.

J Med Virol. 2015 Apr;87(4):589-600. doi: 10.1002/jmv.24115. Epub 2015 Jan 21.

PMID:
25612181
6.

Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.

Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.

Biol Blood Marrow Transplant. 2010 Jun;16(6):809-17. doi: 10.1016/j.bbmt.2009.12.533. Epub 2010 Jan 7.

7.
8.

Mutations associated with occult hepatitis B in HIV-positive South Africans.

Powell EA, Gededzha MP, Rentz M, Rakgole NJ, Selabe SG, Seleise TA, Mphahlele MJ, Blackard JT.

J Med Virol. 2015 Mar;87(3):388-400. doi: 10.1002/jmv.24057. Epub 2014 Aug 27.

9.

Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.

Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A; HepaICONA and the ICONA Study Groups.

Infection. 2009 Oct;37(5):445-9. doi: 10.1007/s15010-008-8194-9. Epub 2009 Aug 7.

PMID:
19669092
10.

HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review.

Du W, Zheng Z, Han S, Ma S, Chen S.

BMC Infect Dis. 2013 Aug 27;13:394. doi: 10.1186/1471-2334-13-394.

11.

Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.

Shetty K, Hussain M, Nei L, Reddy KR, Lok AS.

Liver Transpl. 2008 Apr;14(4):534-40. doi: 10.1002/lt.21284. Erratum in: Liver Transpl. 2011 Jan;17(1):97.

12.

[Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].

Fan LY, Zhou Z, Zhong S, Ling N, Wang ZY, Shi XF, Zhang DZ, Ren H.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):429-33. Chinese.

PMID:
19567021
13.

Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy.

Cheung WI, Chan HL, Leung VK, Tse CH, Fung K, Lin SY, Wong A, Wong VW, Chau TN.

J Clin Virol. 2010 Feb;47(2):193-5. doi: 10.1016/j.jcv.2009.11.024. Epub 2009 Dec 23.

PMID:
20031483
14.

Occult hepatitis B in patients on hemodialysis: a review.

Fontenele AM, Filho NS, Ferreira AS.

Ann Hepatol. 2013 Jul-Aug;12(4):527-31. Review.

15.

Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.

Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.

J Clin Gastroenterol. 2009 May-Jun;43(5):496-8. doi: 10.1097/MCG.0b013e3181945942.

PMID:
19247200
16.
17.

Occult hepatitis B virus infection with positive hepatitis B e antigen.

Han Z, Liu Y, Pan J, Bi Y, Liu J, Zhou YH.

Clin Chim Acta. 2015 Jan 1;438:266-8. doi: 10.1016/j.cca.2014.09.007. Epub 2014 Sep 16.

PMID:
25218700
18.

Occult hepatitis B virus infection: detection and significance.

Gerlich WH, Bremer C, Saniewski M, Schüttler CG, Wend UC, Willems WR, Glebe D.

Dig Dis. 2010;28(1):116-25. doi: 10.1159/000282074. Epub 2010 May 7. Review.

PMID:
20460899
19.

Appearance of HbeAg in an occult persistent hepatitis B virus infection.

Paparella C, De Rosa F, Longo R, Cappiello G, Ursitti A, Rosa M, Morosetti M, Spanò A.

Intervirology. 2010;53(3):173-5. doi: 10.1159/000279765. Epub 2010 Feb 3.

20.

Supplemental Content

Support Center